Keyphrases
Meta-analysis
100%
Progesterone Receptor
100%
Estrogen Receptor
100%
Breast Cancer Risk
100%
Systematic Meta-analysis
100%
Receptor Status
100%
Breast Cancer
80%
Confidence Interval
60%
Odds Ratio
60%
Epidermal Growth Factor Receptor
40%
Human Epidermal Growth Factor Receptor 2 (HER2)
40%
Inverse Association
40%
Breast Cancer Subtypes
40%
Parous Women
40%
Triple-negative Breast Cancer
20%
Young Women
20%
Protective Effect
20%
Poor Prognosis
20%
Prospective Cohort Study
20%
Breast Cancer Cases
20%
Risk Estimation
20%
Publication Bias
20%
Random Effects Model
20%
Full-term Infants
20%
Overall Risk
20%
PubMed Database
20%
Mechanisms of Carcinogenesis
20%
Scopus Database
20%
Hormone Receptor-negative Breast Cancer
20%
Medicine and Dentistry
Receptor
100%
Cancer Risk
100%
Breast Cancer
100%
Meta-Analysis
100%
Systematic Review
100%
Estrogen Receptor
50%
Progesterone Receptor
50%
Odds Ratio
30%
Epidermal Growth Factor Receptor 2
20%
Gamma Urogastrone
20%
Carcinogenesis
10%
Prospective Cohort Study
10%
Cohort Analysis
10%
Random Effects Model
10%
Triple Negative Breast Cancer
10%
Hormone Receptor
10%
Case-Control Study
10%
Pharmacology, Toxicology and Pharmaceutical Science
Receptor
100%
Breast Cancer
100%
Progesterone Receptor
50%
Estrogen Receptor
50%
Epidermal Growth Factor Receptor 2
20%
Gamma Urogastrone
20%
Cohort Study
10%
Triple Negative Breast Cancer
10%
Carcinogenesis
10%
Prospective Cohort Study
10%
Case-Control Study
10%
Random Effects Model
10%
Hormone Receptor
10%
Biochemistry, Genetics and Molecular Biology
Progesterone Receptor
100%
Estrogen Receptor
100%
Epidermal Growth Factor Receptor
40%
Cohort Study
20%
Carcinogenesis
20%
Prospective Cohort Study
20%
Case-Control Study
20%
Hormone Receptor
20%
Medline
20%
Scopus
20%